Adherence, Dosing, and Managing Toxicities With Trifluridine/Tipiracil (TAS-102)

Lee, JJ; Chu, E

Lee, JJ (reprint author), UPMC Canc Pavil,5150 Ctr Ave,5th Floor, Pittsburgh, PA 15232 USA.

CLINICAL COLORECTAL CANCER, 2017; 16 (2): 85

Abstract

Trifluridine/tipiracil (TAS-102) is a new oral combination therapy approved by the US Food and Drug Administration for the treatment of patients with ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索